Aileron Therapeutics Future Growth
Future criteria checks 0/6
Aileron Therapeutics's earnings are forecast to decline at 34.1% per annum. EPS is expected to grow by 13.7% per annum.
Key information
-34.1%
Earnings growth rate
13.7%
EPS growth rate
| Biotechs earnings growth | 27.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Aug 2024 |
Recent future growth updates
Recent updates
Companies Like Aileron Therapeutics (NASDAQ:ALRN) Could Be Quite Risky
Aug 18
Is Aileron Therapeutics (NASDAQ:ALRN) In A Good Position To Deliver On Growth Plans?
Dec 30Aileron Therapeutics: An Assessment On A Lottery Ticket
Oct 21Aileron Therapeutics: Solving Chemotherapy's Toxicity
May 01Aileron Therapeutics +31% on insider buying more shares
Jan 08Aileron raises $40M via equity offering
Jan 06Aileron Therapeutics EPS in-line
Nov 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -62 | N/A | N/A | 2 |
| 12/31/2025 | N/A | -35 | N/A | N/A | 2 |
| 12/31/2024 | N/A | -25 | N/A | N/A | 2 |
| 6/30/2024 | N/A | -25 | -26 | -26 | N/A |
| 3/31/2024 | N/A | -18 | -20 | -20 | N/A |
| 12/31/2023 | N/A | -16 | -20 | -20 | N/A |
| 9/30/2023 | N/A | -13 | -14 | -14 | N/A |
| 6/30/2023 | N/A | -17 | -19 | -19 | N/A |
| 3/31/2023 | N/A | -24 | -22 | -22 | N/A |
| 12/31/2022 | N/A | -27 | -25 | -25 | N/A |
| 9/30/2022 | N/A | -30 | -27 | -27 | N/A |
| 6/30/2022 | N/A | -30 | -27 | -27 | N/A |
| 3/31/2022 | N/A | -28 | -25 | -25 | N/A |
| 12/31/2021 | N/A | -26 | -24 | -24 | N/A |
| 9/30/2021 | N/A | -24 | -22 | -22 | N/A |
| 6/30/2021 | N/A | -23 | -20 | -20 | N/A |
| 3/31/2021 | N/A | -21 | -21 | -21 | N/A |
| 12/31/2020 | N/A | -21 | -20 | -20 | N/A |
| 9/30/2020 | N/A | -23 | -22 | -22 | N/A |
| 6/30/2020 | N/A | -26 | -24 | -24 | N/A |
| 3/31/2020 | N/A | -29 | -25 | -25 | N/A |
| 12/31/2019 | N/A | -29 | -27 | -26 | N/A |
| 9/30/2019 | N/A | -29 | -29 | -27 | N/A |
| 6/30/2019 | N/A | -29 | -31 | -27 | N/A |
| 3/31/2019 | N/A | -31 | -33 | -28 | N/A |
| 12/31/2018 | N/A | -32 | -32 | -28 | N/A |
| 9/30/2018 | N/A | -31 | -30 | -27 | N/A |
| 6/30/2018 | N/A | -30 | -26 | -25 | N/A |
| 3/31/2018 | N/A | -26 | N/A | -22 | N/A |
| 12/31/2017 | N/A | -23 | N/A | -21 | N/A |
| 9/30/2017 | N/A | -20 | N/A | -19 | N/A |
| 6/30/2017 | N/A | -18 | N/A | -18 | N/A |
| 3/31/2017 | N/A | -19 | N/A | -17 | N/A |
| 12/31/2016 | N/A | -18 | N/A | -15 | N/A |
| 9/30/2016 | N/A | -17 | N/A | -14 | N/A |
| 6/30/2016 | N/A | -16 | N/A | -12 | N/A |
| 3/31/2016 | N/A | -14 | N/A | -12 | N/A |
| 12/31/2015 | N/A | -13 | N/A | -12 | N/A |
| 9/30/2015 | N/A | -13 | N/A | -13 | N/A |
| 6/30/2015 | N/A | -13 | N/A | -12 | N/A |
| 3/31/2015 | N/A | -15 | N/A | -15 | N/A |
| 12/31/2014 | N/A | -16 | N/A | -17 | N/A |
| 12/31/2013 | 22 | 0 | N/A | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALRN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALRN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALRN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if ALRN's revenue is forecast to grow faster than the US market.
High Growth Revenue: ALRN is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALRN's Return on Equity is forecast to be high in 3 years time